|
1
|
Dahl EV, Waugh JM and Dahlin DC:
Gastrointestinal ganglioneuromas; brief review with report of a
duodenal ganglioneuroma. Am J Pathol. 33:953–965. 1957.PubMed/NCBI
|
|
2
|
Okubo Y, Yoshioka E, Suzuki M, Washimi K,
Kawachi K, Kameda Y and Yokose T: Diagnosis, pathological findings,
and clinical management of gangliocytic paraganglioma: A systematic
review. Front Oncol. 8(291)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Matsubayashi H, Ishiwatari H, Matsui T,
Fujie S, Uesaka K, Sugiura T, Okamura Y, Yamamoto Y, Ashida R, Ito
T, et al: Gangliocytic paraganglioma of the minor papilla of the
duodenum. Intern Med. 56:1029–1035. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chiang CS, Shyr BU, Chen SC, Shyr YM and
Wang SE: Periampullary gangliocytic paraganglioma. J Gastrointest
Surg. 23:2247–2254. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Weinrach DM, Wang KL, Blum MG, Yeldandi AV
and Laskin WB: Multifocal presentation of gangliocytic
paraganglioma in the mediastinum and esophagus. Hum Pathol.
35:1288–1291. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Palacio D, Jo N, Del Pilar Gutierrez M,
Shponka V and Betancourt S: Multimodality imaging appearance of
intrapericardial paragangliomas. Clin Radiol. 77:952–959.
2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Naso JR, Wang D, Romero AO, Leclair T,
Smit P, Boland JM, Folpe AL and Bois MC: Pulmonary gangliocytic
paraganglioma: An under-recognized mimic of carcinoid tumor. Hum
Pathol. 146:23–27. 2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mete O, Asa SL, Gill AJ, Kimura N, de
Krijger RR and Tischler A: Overview of the 2022 WHO classification
of paragangliomas and pheochromocytomas. Endocr Pathol. 33:90–114.
2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Park HK and Han HS: Duodenal gangliocytic
paraganglioma with lymph node metastasis. Arch Pathol Lab Med.
140:94–98. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ramos-Vara JA: Principles and methods of
immunohistochemistry. Methods Mol Biol. 1641:115–128.
2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rindi G, Mete O, Uccella S, Basturk O, La
Rosa S, Brosens LAA, Ezzat S, de Herder WW, Klimstra DS, Papotti M
and Asa SL: Overview of the 2022 WHO classification of
neuroendocrine neoplasms. Endocr Pathol. 33:115–154.
2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Helderman NC, Suerink M, Kilinç G, van den
Berg JG, Nielsen M and Tesselaar MET: Relation between WHO
classification and location- and functionality-based
classifications of neuroendocrine neoplasms of the digestive tract.
Neuroendocrinology. 114:120–133. 2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Oronsky B, Ma PC, Morgensztern D and
Carter CA: Nothing but NET: A review of neuroendocrine tumors and
carcinomas. Neoplasia. 19:991–1002. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sanli Y, Garg I, Kandathil A, Kendi T,
Zanetti MJB, Kuyumcu S and Subramaniam RM: Neuroendocrine tumor
diagnosis and management: 68Ga-DOTATATE PET/CT. AJR Am J
Roentgenol. 211:267–277. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li J, Wang LP and Zhu PS: Is gangliocytic
paraganglioma designated as a subtype of composite paragangliomas
and originated from pancreas islet? A case report and review of
literature. Front Endocrinol (Lausanne). 13(847632)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang B, Zou Y, Zhang H, Xu L, Jiang X and
Sun K: Duodenal gangliocytic paraganglioma: Report of two cases and
review of literature. Int J Clin Exp Pathol. 8:9752–9759.
2015.PubMed/NCBI
|
|
17
|
Furihata M, Sonobe H, Iwata J, Ido E,
Ohtsuki Y and Ohnishi S: Immunohistochemical characterization of a
case of duodenal gangliocytic paraganglioma. Pathol Int.
46:610–613. 1996.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Rubisz P, Ciebiera M, Hirnle L,
Zgliczyńska M, Łoziński T, Dzięgiel P and Kobierzycki C: The
usefulness of immunohistochemistry in the differential diagnosis of
lesions originating from the myometrium. Int J Mol Sci.
20(1136)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Harries K, Nunn T, Shah V, Richards D and
Manson JM: First reported case of esophageal paraganglioma. A
review of the literature of gastrointestinal tract paraganglioma
including gangliocytic paraganglioma. Dis Esophagus. 17:191–195.
2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nonaka K, Matsuda Y, Okaniwa A, Kasajima
A, Sasano H and Arai T: Pancreatic gangliocytic paraganglioma
harboring lymph node metastasis: A case report and literature
review. Diagn Pathol. 12(57)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Seo G, Park J, Lee E, Han J, Kim D, Kim D,
Park J, Kwag M and Jung S: Gangliocytic paraganglioma of the
gastrointestinal tract: A case report of cecal origin. Curr Med
Imaging. 18:95–98. 2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Usuda H and Emura I: Composite
paraganglioma-ganglioneuroma of the urinary bladder. Pathol Int.
55:596–601. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Nagtegaal ID, Odze RD, Klimstra D, Paradis
V, Rugge M, Schirmacher P, Washington KM, Carneiro F and Cree IA:
WHO Classification of Tumours Editorial Board. The 2019 WHO
classification of tumours of the digestive system. Histopathology.
76:182–188. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Choi H, Choi JW, Ryu DH, Park S, Kim MJ,
Yoo KC and Woo CG: Ampullary gangliocytic paraganglioma with lymph
node metastasis: A case report with literature review. Medicine
(Baltimore). 101(e29138)2022.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li B, Li Y, Tian XY, Luo BN and Li Z:
Malignant gangliocytic paraganglioma of the duodenum with distant
metastases and a lethal course. World J Gastroenterol.
20:15454–15461. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sharma S, Gaspar BL, Kumar P, Yadav TD and
Vasishta RK: Gangliocytic paraganglioma with atypical
immunohistochemical features presenting as extrahepatic biliary
obstruction. Int J Surg Pathol. 23:561–566. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Serrano C, Martin-Broto J, Asencio-Pascual
JM, Lopez-Guerrero JA, Rubio-Casadevall J, Bague S, Garcia-Del-Muro
X, Fernandez-Hernandez JA, Herrero L, Lopez-Pousa A, et al: 2023
GEIS guidelines for gastrointestinal stromal tumors. Ther Adv Med
Oncol. 15(17588359231192388)2023.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Munteanu A, Patrascu S, Bordu S, Laskou S,
Surlin V and Radu P: Clinical and morphological characteristics of
gastrointestinal stromal tumor. Chirurgia (Bucur). 118:618–623.
2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Virani N, Pang J and Lew M: Cytologic and
immunohistochemical evaluation of low-grade spindle cell lesions of
the gastrointestinal tract. Arch Pathol Lab Med. 140:1038–1044.
2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Goldberg JL, Tong J and McGrath LB Jr:
Spinal ganglioneuroma. World Neurosurg. 162:15–16. 2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Barret M, Rahmi G, van Huyen JP, Landi B,
Cellier C and Berger A: Duodenal gangliocytic paraganglioma with
lymph node metastasis and an 8-year follow-up: A case report. Eur J
Gastroenterol Hepatol. 24:90–94. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Hernandez AG, Lanuza ED, Matias AC,
Huertas RP, Rodriguez KM, Perez PG and Mompean FO: Large
gangliocytic paraganglioma of the duodenum: A rare entity. World J
Gastrointest Surg. 7:170–173. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Okubo Y: Gangliocytic paraganglioma: An
overview and future perspective. World J Clin Oncol. 10:300–302.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang Z, Tu Z, Lv Z, Luo Y and Yuan J:
Case report: Totally laparoscopic resection of retroperitoneal
paraganglioma masquerading as a duodenal gastrointestinal stromal
tumor. Front Surg. 8(586503)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Moriyama H, Asai K, Watanabe R, Nagata T,
Futawatari N, Enomoto T, Nagao S, Watanabe M, Oharazeki T and Saida
Y: Laparoscopic tumor resection for asymptomatic paraganglioma-a
case study. Gan To Kagaku Ryoho. 50:1924–1927. 2023.PubMed/NCBI(In Japanese).
|
|
36
|
Cathcart SJ, Sasson AR, Kozel JA, Oliveto
JM and Ly QP: Duodenal gangliocytic paraganglioma with lymph node
metastases: A case report and comparative review of 31 cases. World
J Clin Cases. 5:222–233. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lamberts SW, Hofland LJ and Nobels FR:
Neuroendocrine tumor markers. Front Neuroendocrinol. 22:309–339.
2001.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Stueven AK, Kayser A, Wetz C, Amthauer H,
Wree A, Tacke F, Wiedenmann B, Roderburg C and Jann H: Somatostatin
analogues in the treatment of neuroendocrine tumors: Past, present
and future. Int J Mol Sci. 20(3049)2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Nesti C, Bräutigam K, Benavent M, Bernal
L, Boharoon H, Botling J, Bouroumeau A, Brcic I, Brunner M, Cadiot
G, et al: Hemicolectomy versus appendectomy for patients with
appendiceal neuroendocrine tumours 1-2 cm in size: A retrospective,
Europe-wide, pooled cohort study. Lancet Oncol. 24:187–194.
2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Saif MW: Lanreotide for the treatment of
gastroenteropancreatic neuroendocrine tumors. Expert Opin
Pharmacother. 17:443–456. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Caplin ME, Pavel M, Phan AT, Ćwikła JB,
Sedláčková E, Thanh XT, Wolin EM and Ruszniewski P: CLARINET
Investigators. Lanreotide autogel/depot in advanced
enteropancreatic neuroendocrine tumours: Final results of the
CLARINET open-label extension study. Endocrine. 71:502–513.
2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Becx MN, Minczeles NS, Brabander T, de
Herder WW, Nonnekens J and Hofland J: A clinical guide to peptide
receptor radionuclide therapy with 177Lu-DOTATATE in
neuroendocrine tumor patients. Cancers (Basel).
14(5792)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mittra ES: Neuroendocrine tumor therapy:
177Lu-DOTATATE. AJR Am J Roentgenol. 211:278–285.
2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Strosberg JR, Caplin ME, Kunz PL,
Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, Yao JC,
Pavel ME, et al: 177Lu-Dotatate plus long-acting
octreotide versus high-dose long-acting octreotide in patients with
midgut neuroendocrine tumours (NETTER-1): Final overall survival
and long-term safety results from an open-label, randomised,
controlled, phase 3 trial. Lancet Oncol. 22:1752–1763.
2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Chan DL and Singh S: Current chemotherapy
use in neuroendocrine tumors. Endocrinol Metab Clin North Am.
47:603–614. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hijioka S, Morizane C, Ikeda M, Ishii H,
Okusaka T and Furuse J: Current status of medical treatment for
gastroenteropancreatic neuroendocrine neoplasms and future
perspectives. Jpn J Clin Oncol. 51:1185–1196. 2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Morken S, Langer SW, Sundlöv A, Vestermark
LW, Ladekarl M, Hjortland GO, Svensson JB, Tabaksblat EM, Haslerud
TM, Assmus J, et al: Phase II study of everolimus and temozolomide
as first-line treatment in metastatic high-grade
gastroenteropancreatic neuroendocrine neoplasms. Br J Cancer.
129:1930–1939. 2023.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Ooki A, Osumi H, Fukuda K and Yamaguchi K:
Potent molecular-targeted therapies for gastro-entero-pancreatic
neuroendocrine carcinoma. Cancer Metastasis Rev. 42:1021–1054.
2023.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Capdevila J, Hernando J, Teule A, Lopez C,
Garcia-Carbonero R, Benavent M, Custodio A, Garcia-Alvarez A,
Cubillo A, Alonso V, et al: Durvalumab plus tremelimumab for the
treatment of advanced neuroendocrine neoplasms of
gastroenteropancreatic and lung origin. Nat Commun.
14(2973)2023.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Del Rivero J, Perez K, Kennedy EB, Mittra
ES, Vijayvergia N, Arshad J, Basu S, Chauhan A, Dasari AN, Bellizzi
AM, et al: Systemic therapy for tumor control in metastatic
well-differentiated gastroenteropancreatic neuroendocrine tumors:
ASCO guideline. J Clin Oncol. 41:5049–5067. 2023.PubMed/NCBI View Article : Google Scholar
|
